Clinical practice. Prevention of meningococcal disease.
Gardner
Pierce
P
Department of Medicine and the Graduate Program in Public Health, Stony Brook University School of Medicine, Stony Brook, NY, USA.
D000293:Adolescent; D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002443:Ceftriaxone / Q000627:therapeutic use; D002648:Child; D002939:Ciprofloxacin / Q000627:therapeutic use; D004196:Disease Outbreaks; D006801:Humans; D008297:Male; D008589:Meningococcal Infections / Q000453:epidemiology / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000276:immunology; D009345:Neisseria meningitidis; D017410:Practice Guidelines as Topic; D012293:Rifampin / Q000627:therapeutic use; D014481:United States / Q000453:epidemiology; D018074:Vaccines, Conjugate / Q000276:immunology
D000890:Anti-Infective Agents; D022401:Meningococcal Vaccines; D018074:Vaccines, Conjugate; D002939:Ciprofloxacin; D002443:Ceftriaxone; D012293:Rifampin